Global Automated Breast Ultrasound System (ABUS) Market Size, Growth Analysis and Forecast Insights

Report ID : 1292555 | Published : February 2025 | Study Period : 2023-2033 | Format : PDF + Excel

The market size of the Automated Breast Ultrasound System (ABUS) Market is categorized based on Technology (2D Ultrasound, 3D Ultrasound, 4D Ultrasound) and End User (Hospitals, Diagnostic Imaging Centers, Research Institutes) and Application (Breast Cancer Screening, Breast Cancer Diagnosis, Monitoring of Breast Tumors) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The Automated Breast Ultrasound System (ABUS) Market size was valued at $450 million in 2023 and is projected to reach $1.2 billion by 2033, growing at a CAGR of 10.3% from 2024 to 2033. This report includes various market segments and analyzes the key trends and factors influencing market growth.

Over the years, the Automated Breast Ultrasound System market has seen considerable growth. This growth can be attributed to an increase in recognition from healthcare providers regarding the impact of early intervention on diagnosis and treatment of breast cancer. These advanced imaging systems aim to augment breast examinations’ effectiveness, especially centrals for women with dense breast tissue towards whom traditional mammography proves ineffective. Other than assisting diagnosis, ABUS sharpens the patient outcome and experience by being non-invasive and painless. Moreover, the improved outcome leads to dual benefit for the patients. The shift towards more advanced screening methods is revolutionizing breast cancer screening which requires keen interest from healthcare professionals, researchers, and desicion makers in the industry.

ABUS systems require sophisticated ultrasound examinations that are easier than traditional methods, especially for women, due to the increased need and demand for efficient and accurate breast cancer screening. Therefore, it is safe to conclude that the ABUS sector will expand further, especially with the increasing sophistication in imaging technology and strong government focus on women’s health. In addition, the ABUS systems have low economic and time efficiency; thus, healthcare systems are incorporating them and proving conventional methods for alternate diagnosis. The evolving market is presenting new avenues for stakeholders from different sectors, including breast cancer manufacturers, to integrate and enhance worldwidem breast cancer screening techniques.

 

ATTRIBUTES	DETAILS
STUDY PERIOD	2023-2033
BASE YEAR	2023
FORECAST PERIOD	2024-2033
HISTORICAL PERIOD	2023-2024
UNIT	VALUE (USD BILLION)
KEY COMPANIES PROFILED	GE Healthcare, Siemens Healthineers, Philips Healthcare, Fujifilm Holdings Corporation, Canon Medical Systems, Hologic Inc., Mindray Medical International Limited, Samsung Medison, Esaote S.p.A., Hitachi Ltd., Bracco Imaging S.p.A.
SEGMENTS COVERED	By Technology - 2D Ultrasound, 3D Ultrasound, 4D Ultrasound By End User - Hospitals, Diagnostic Imaging Centers, Research Institutes By Application - Breast Cancer Screening, Breast Cancer Diagnosis, Monitoring of Breast Tumors By Geography - North America, Europe, APAC, Middle East Asia & Rest of World.

---

Automated Breast Ultrasound System (ABUS) Market Dynamics

The Automated Breast Ultrasound System (ABUS) Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.

Market Drivers

1. Technological Advancements
2. Increasing Consumer Demand
3. Regulatory Support
4. Globalization

Market Restraints

1. High Operational Costs
2. Regulatory Challenges
3. Market Saturation

Market Opportunities

1. Emerging Markets
2. Product Innovation
3. Strategic Partnerships

Market Challenges

1. Technological Disruptions
2. Supply Chain Issues
3. Changing Consumer Preferences

---

Key Players in the Automated Breast Ultrasound System (ABUS) Market

This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Fujifilm Holdings Corporation
• Canon Medical Systems
• Hologic Inc.
• Mindray Medical International Limited
• Samsung Medison
• Esaote S.p.A.
• Hitachi Ltd.
• Bracco Imaging S.p.A.

---

Customization Options

Verified Industry Insights offers one of the following report customization options to our respectable clients :

Company Profiling

● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)

Competitive Benchmarking

● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research

Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439

© 2024 Verified Industry Insights. All Rights Reserved